Peregrine Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.7M | Buy |
|
|||||
|
2025
Q1 | $30.5M | Sell |
|
|||||
|
2024
Q4 | $41M | Sell |
|
|||||
|
2024
Q3 | $52.1M | Sell |
|
|||||
|
2024
Q2 | $32.5M | Buy |
|
|||||
|
2024
Q1 | $45.2M | Sell |
|
|||||
|
2023
Q4 | $48.7M | Buy |
|
|||||
|
2023
Q3 | $38.3M | Sell |
|
|||||
|
2023
Q2 | $52.8M | Sell |
|
|||||
|
2023
Q1 | $38.5M | Sell |
|
|||||
|
2022
Q4 | $30M | Buy |
|
|||||
|
2022
Q3 | $14.3M | Sell |
|
|||||
|
2022
Q2 | $17.6M | Sell |
|
|||||
|
2022
Q1 | $32.8M | Sell |
|
|||||
|
2021
Q4 | $39.8M | Buy |
|
|||||
|
2021
Q3 | $36.2M | Buy |
|
|||||
|
2021
Q2 | $43.2M | Buy |
|
|||||
|
2021
Q1 | $40.1M | Buy |
|
|||||
|
2020
Q4 | $37.4M | Buy |
|
|||||
|
2020
Q3 | $24.8M | Buy |
|